Born in 1974. Member of the Board since 2013. Chairman of the remuneration committee.
Education and relevant experience:
Saeid Esmaeilzadeh holds a Ph.D. in Chemistry from the Stockholm University. Saeid Esmaeilzadeh has been rewarded several awards for research and entrepreneurial accomplishments. He is the founder of several innovative companies within CleanTech, MedTech and Advanced Materials.
Other current assignments:
Chairman of the board of Serendipity Ixora AB, Premune AB and S. Professionals AB. Board member in Diamorph AB, Sdiptech AB, Episurf Medical AB, Serendipity Group AB, Swecure AB, Nextseal AB, Build-r AB, Nextmune MC AB, Nextmune HoldCo AB, Nextmune AB and Xbrane Biopharma AB. Deputy board member of Serendip Invest AB, VZL Vilande AB, Auremune AB, Leonova CONSULTING AB, Premune IPR AB, Swecure Europe AB, Intelligent Art AB, Swecure IPR AB, Serendipity Innovations AB, DynaSeal LCT AB and Serendipity Ventures AB.
Shareholding in IRRAS: 678,233 shares.
Saeid Esmaeilzadeh is independent in relation to the company and its management but not in relation to major shareholders.